PURE X
Alternative Names: Patient Pure X™; PPX™Latest Information Update: 05 Apr 2024
At a glance
- Originator Organicell
- Class Exosome therapies; MicroRNAs; Neuroprotectants; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Autoimmune disorders; Musculoskeletal disorders; Neurological disorders
Most Recent Events
- 21 Feb 2023 Discontinued for Autoimmune disorders in USA (Parenteral) (Organicell pipeline, February 2023)
- 21 Feb 2023 Discontinued for Musculoskeletal disorders in USA (Parenteral) (Organicell pipeline, February 2023)
- 21 Feb 2023 Discontinued for Neurological disorders in USA (Parenteral) (Organicell pipeline, February 2023)